MusclePharm Corporation — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6d69703b-b09c-4996-a987-5d40ed4dcdf4/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-8.9M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-010161 |
| FY 2020 | $2.6M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-007088 |
| FY 2019 | $-15.1M | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-009485 |
| FY 2018 | $-7.8M | 2018-01-01 – 2018-12-31 | evidence 0001654954-20-009485 |
| FY 2017 | $-6.6M | 2017-01-01 – 2017-12-31 | evidence 0001654954-20-009485 |
| FY 2016 | $-8.7M | 2016-01-01 – 2016-12-31 | evidence 0001415684-17-000012 |
| FY 2015 | $-49.9M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-507417 |
| FY 2014 | $-19.4M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001728 |
| FY 2013 | $-14.3M | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-001728 |
| FY 2012 | $-8.7M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-001728 |
| FY 2011 | $-16.2M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-021909 |
| FY 2010 | $-18.3M | 2010-01-01 – 2010-12-31 | evidence 0001144204-11-054873 |
| FY 2009 | $-1.8M | 2009-01-01 – 2009-12-31 | evidence 0001144204-11-054873 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).